Check out your Company Bowl for anonymous work chats.
Absci and AMD to Accelerate Breakthroughs in AI Drug Discovery $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm Software
